Veterans’ RightsAn independent resource for veterans
← All decisions
Remanded (sent back)

The Board has remanded the claim of service connection for prostate cancer due to exposure to Agent Orange, as it is unclear if the Veteran was exposed during his time in Okinawa, Japan. The RO needs to make updated requests to DPRIS regarding this potential exposure.

The deciding factor: There are insufficient records indicating the Veteran's exposure to herbicide agent (Agent Orange) at Okinawa, Japan, specifically.

Claimed conditions
prostate cancer
How they argued it
Presumptive (no nexus needed)
Exposure basis
Agent Orange / herbicides
Rating assigned
None in this decision
Decision date
October 25, 2022
Citation
22059729

This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 22059729.

What this means for you

A remand is not a loss. The Board sent the case back for more development — often a new exam or missing records — before making a final decision. Many remands later end in a grant, and the decision spells out exactly what the Board wanted to see.

What you can do next

Related decisions

Other Board decisions on a similar condition or argued the same way.

Free starter guide for your own claim

Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.

We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.

We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.

This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.